Stocks Health care CERS

NASDAQ · Health care

Cerus Corp (CERS)

It posted a net loss of $6.8M. Operating cash flow minus capital spending left $1.1M of free cash flow in fiscal 2025. At June 30, 2026 it held $18M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on July 30, 2026.

What Cerus Corp does

Cerus Corp is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker CERS.

Revenue and profit by year

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Where CERS ranks in Health care

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What Cerus Corp has filed recently, newest first. Each links to the original document on SEC EDGAR.

1. August 14, 2026
   Passive stake changed SCHEDULE 13G/A
2. August 14, 2026
   Passive stake changed SCHEDULE 13G/A
3. August 13, 2026
   Passive stake changed SCHEDULE 13G/A
4. July 30, 2026
   Employee stock plan registration S-8
5. July 30, 2026
   Quarterly report 10-Q · period to June 30, 2026
6. July 30, 2026
   Quarterly results 8-K
7. July 10, 2026
   Executive or director change 8-K
8. June 8, 2026
   Material agreement 8-K
9. June 3, 2026
   Executive or director change 8-K
10. May 29, 2026
    Conflict minerals disclosure SD

Recent insider filings (Forms 3, 4 and 144): 10, the latest on August 17, 2026. Insider transactions on SEC

What is CERS worth? A DCF from its reported cash flow

Insider trades

What the people running Cerus Corp did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

All insider filings on SEC.gov · Where insiders are buying across the market

All filings on SEC EDGAR

Questions about CERS

What does Cerus Corp do?

Cerus Corp is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker CERS.

Is Cerus Corp profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $6.8M.

When did Cerus Corp last report?

Its most recent periodic report is the quarterly report (10-Q) filed on July 30, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from August 17, 2026.

Similar companies

Compare CERS with

Compare CERS with any company

Follow CERS

Get an email when Cerus Corp files with the SEC: results, executive changes, material agreements and annual reports.

Follow CERS: get an email when it files

Where the numbers come from

Financial figures are the values Cerus Corp tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.